Order results by:
Issue | Title | |
Vol 15, No 1 (2022) | The analysis of the consumption level of antihypertensive drugs and statins in a retail pharmacy of the Samara Region in 2015–2020 | Abstract similar documents |
I. K. Petrukhina, P. A. Lebedev, E. P. Gladunova, T. K. Ryazanova, A. A. Garanin, P. R. Blinkova | ||
Vol 14, No 1 (2021) | History of controlled trials in medicine: real priorities are little-known. Report 1. Basic concepts, terms, and disciplines that use medical experiment: historical and philosophical sources | Abstract similar documents |
A. N. Koterov, O. A. Tikhonova, L. N. Ushenkova, A. P. Biryukov | ||
Vol 14, No 3 (2021) | History of controlled trials in medicine: real priorities are little-known. Report 2. From early experiments to the present day: without alternation and randomization | Abstract similar documents |
A. N. Koterov, O. A. Tikhonova, L. N. Ushenkova, A. P. Biryukov | ||
"... on the history of CT is J.P. Bull’s dissertation (1951). The formed database as of July 2020 contained more than ..." | ||
Vol 14, No 4 (2021) | History of controlled trials in medicine: real priorities are little-known. Report 3. Quasi-randomized and randomized trials in humans and animals | Abstract similar documents |
A. N. Koterov, O. A. Tikhonova, L. N. Ushenkova, A. P. Biryukov | ||
"... according to the table of random numbers, was J.A. Bell, 1941 (USA). Often referred to as the ‘new era in CT ..." | ||
Vol 13, No 4 (2020) | Pharmacoeconomic analysis of first-choice antimicrobial drugs prescribed for outpatient treatment of non-severe community-acquired pneumonia | Abstract similar documents |
V. G. Deriushkin, A. P. Ternavskii, S. V. Gatsura | ||
Vol 14, No 2 (2021) | Impact of disease information (Ebola and COVID-19) on the pharmaceutical sector in Russia and USA | Abstract similar documents |
E. A. Fedorova, D. O. Afanasyev, A. V. Sokolov, M. P. Lazarev | ||
Vol 14, No 3 (2021) | Pharmacoeconomic analysis of the application of strong opioids for the treatment of chronic pain syndrome in patients with pancreatic cancer | Abstract similar documents |
O. P. Bobrova, S. K. Zyryanov, N. A. Shnayder, M. M. Petrova | ||
Vol 16, No 2 (2023) | Pharmacoeconomic analysis of tixagevimab and cilgavimab combination for COVID-19 therapy | Abstract similar documents |
M. V. Zhuravleva, V. P. Chulanov, Yu. V. Gagarina, E. A. Shabalina | ||
Vol 16, No 1 (2023) | Cost-effectiveness analysis of using atorvastatin, simvastatin, ezetimibe, alirocumab, evolocumab, inclisiran in adults with very high cardiovascular risk under the preferential drug provision program | Abstract similar documents |
T. O. Bessonova, P. A. Mukhortova, R. A. Teryan, A. D. Bagdasarov, N. Z. Musina | ||
Vol 16, No 4 (2023) | Sales of antitumor drugs in the retail segment of the Russian pharmaceutical market | Abstract similar documents |
I. K. Petrukhina, T. K. Ryazanova, E. P. Gladunova, A. M. Lazarev, A. A. Krivova | ||
"... B Antimetabolites, L02A Hormones and related compounds and L02B Hormone antagonists and related ..." | ||
Vol 16, No 4 (2023) | Pharmacoeconomic study of fluorescent lymphography and radionuclide diagnostics methods for sentinel lymph node detection in breast cancer | Abstract similar documents |
E. P. Kulikov, M. V. Shomova, D. S. Titov, A. N. Demko, M. A. Maistrenko | ||
"... significantly lower than the median CERRD values by average of 43.29% (p<0.001): from 40.36% (p<0.001) to 44 ..." | ||
Online First | Analysis of the availability of bronchodilators and anti-inflammatory drugs for patients with chronic obstructive pulmonary disease | Abstract similar documents |
E. A. Orlova, V. I. Petrov, I. P. Dorfman, O. V. Shatalova, M. A. Orlov | ||
Vol 14, No 3 (2021) | Peculiarities of administration of medications to patients with circulatory system diseases within the framework of the federal program of preferential provision of medicines | Abstract similar documents |
I. K. Petrukhina, R. I. Yagudina, N. V. Veyner, T. K. Ryazanova, E. P. Gladunova, V. A. Kurkin, P. R. Blinkova, E. N. Zaitseva | ||
Online First | Chemoreactomic analysis of acyzole in comparison with zinc derivatives of non-steroidal anti-inflammatory drugs | Abstract similar documents |
P. A. Galenko-Yaroshevsky, I. Yu. Torshin, A. N. Gromov, O. A. Gromova, R. A. Murashko, A. V. Zelenskaya, L. O. Alukhanyan, O. V. Shelemekh | ||
Vol 13, No 3 (2020) | The review of the foreign experience on the financing of innovative medical technologies | Abstract similar documents |
V. V. Omelyanovskiy, I. A. Zheleznyakova, T. P. Bezdenezhnykh, M. L. Lazareva, D. V. Fedyaev | ||
Vol 16, No 2 (2023) | Сlinical and economic evaluation of various etiotropic chemotherapy regimens in patients with respiratory tuberculosis with multidrug and extensively drug resistance | Abstract similar documents |
N. Yu. Nikolenko, D. A. Kudlay, S. E. Borisov, T. E. Sannikova, N. P. Doktorova | ||
Vol 16, No 2 (2023) | Real-world data: principles of use in decision making and in health technology assessment | Abstract similar documents |
V. V. Omelyanovskiy, F. V. Gorkavenko, N. V. Ignatyeva, P. A. Mukhortova, O. R. Ryzhova, T. S. Teptsova, A. A. Kingshott, B. B. Kondratyeva | ||
Vol 16, No 1 (2023) | Efficiency of Levilimab in patients with moderate and severe COVID-19 | Abstract similar documents |
Yu. M. Gomon, V. V. Strizheletsky, I. G. Ivanov, Yu. E. Balykina, M. V. Ermolyev, A. S. Kolbin, M. V. Livshits, T. A. Usmanova, A. M. Fakhrutdinova, Yu. S. Konstantinova, A. P. Gubanov | ||
"... % confidence interval (CI) 1.19–2.47; p<0.01) and for the severe course of COVID-19 (63% and 82%, respectively ..." | ||
Vol 13, No 2 (2020) | Analysis of 19.9 million publications from the PubMed/MEDLINE database using artificial intelligence methods: approaches to the generalizations of accumulated data and the phenomenon of “fake news | Abstract similar documents |
I. Yu. Torshin, O. A. Gromova, L. V. Stakhovskaya, N. P. Vanchakova, A. N. Galustyan, Zh. D. Kobalava, T. R. Grishina, A. N. Gromov, I. A. Ilovaiskaya, V. M. Kodentsova, A. G. Kalacheva, O. A. Limanova, V. A. Maksimov, S. I. Malyavskaya, E. V. Mozgovaya, N. I. Tapilskaya, K. V. Rudakov, V. A. Semenov | ||
Vol 14, No 2 (2021) | Pharmacoepidemiology and pharmacoeconomics of multidrug- and extensively drug-resistant tuberculosis | Abstract similar documents |
N. Yu. Nikolenko, D. А. Kudlay, N. P. Doktorova | ||
Vol 15, No 4 (2022) | Concentration of vitamin D metabolite – 25(OH)D3 as a predictor of breast cancer progression | Abstract similar documents |
D. Е. Frolova, N. P. Lapochkina, О. А. Gromova, I. Yu. Torshin | ||
Vol 14, No 1 (2021) | Review of foreign experience in the implementation of eHealth | Abstract similar documents |
P. V. Minaev, D. V. Fedyaev, Yu. V. Seryapina, T. V. Skomorokhova | ||
Vol 12, No 1 (2019) | Individual cost accounting in the management of medical organizations | Abstract similar documents |
I. A. Zheleznyakova, L. A. Kovaleva, T. A. Khelisupali | ||
Vol 12, No 1 (2019) | Effective search for potentially innovative scientific results in medicine | Abstract similar documents |
M. B. Khrustalev, A. A. Maksimova | ||
Vol 15, No 4 (2022) | Analysis of the main indicative values of the pharmaceutical market retail sectors in the constituent entities of the Russian Federation | Abstract similar documents |
I. К. Petrukhina, Т. К. Ryazanova, А. I. Khusainova, А. V. Egorova, P. R. Blinkova | ||
Vol 14, No 4 (2021) | Features of intellectual property protection mechanisms on the example of orphan drugs circulation | Abstract similar documents |
D. S. Yurochkin, К. V. Nasonova, Z. М. Golant, I. А. Narkevich, V. P. Trukhin | ||
Vol 12, No 1 (2019) | Prevalence survey of musculoskeletal and connective tissue disorders in the Russian Federation | Abstract similar documents |
T. A. Oleynikova, D. N. Pozhidaeva, A. Yu. Oreshko | ||
Vol 14, No 4 (2021) | Machine learning based on laboratory data for disease prediction | Abstract similar documents |
A. V. Gusev, R. E. Novitskiy, A. A. Ivshin, A. A. Alekseev | ||
Vol 15, No 4 (2022) | Historical milestones of the invention and use of placebo | Abstract similar documents |
A. N. Koterov | ||
"... терапевтического, так и экспериментального плацебо. В первом случае пионерами должны быть названы A. Sutherland ..." | ||
Vol 14, No 4 (2021) | Application of medical products: mandatory requirements, supervision of their compliance | Abstract similar documents |
O. A. Makhova | ||
Vol 16, No 4 (2023) | DMOADs and DMARDs in the treatment of patients with joint and spine diseases | Abstract PDF (Eng) similar documents |
O. A. Shavlovskaya | ||
Vol 14, No 2 (2021) | Survey-based evaluation of the awareness of pharmaceutical specialists on the pharmacotherapy of climacteric syndrome | Abstract similar documents |
M. A. Chernyavskaya, I. A. Narkevich | ||
Vol 13, No 2 (2020) | Biological effects of phytoestrogens: clinical effectiveness and potential application in the treatment of climacteric syndrome | Abstract similar documents |
M. A. Chernyavskaya, I. A. Narkevich | ||
Vol 16, No 4 (2023) | Development of approaches to the evaluation of pharmacotherapy effectiveness for chronic hepatitis C | Abstract similar documents |
I. A. Narkevich, E. A. Tsitlionok | ||
Vol 15, No 1 (2022) | The real practice of clinical and economic research of drugs included in the Federal Program of High-Cost Nosologies | Abstract similar documents |
A. S. Kolbin, Yu. M. Gomon, A. R. Kasimova, A. A. Kurylev, A. E. Bem | ||
Vol 15, No 2 (2022) | Clinical study of real-time polymerase chain reaction test kit for SARS-CoV-2 ribonucleic acids detection | Abstract similar documents |
M. Yu. Dmitryukova, A. A. Golod, M. E. Senina, A. E. Gushchin | ||
Vol 14, No 2 (2021) | Effect of vitamin D intake on quality of life parameters in office workers | Abstract similar documents |
A. T. Sharman, Sh. K. Adambekov, A. A. Imandosova, G. F. Elemesova | ||
"... .e. its insufficiency occurs, and <20 ng/ml – as vitamin D deficiency (p<0.0001). The SF-36 score showed ..." | ||
Vol 13, No 2 (2020) | Review of calculation methods, procedures for registration and re-registration of producer prices of medicines in the countries of the Eurasian Economic Union | Abstract similar documents |
A. A. Leshkevich, D. S. Yurochkin, Z. M. Golant, I. A. Narkevich | ||
Vol 13, No 3 (2020) | Chemomicrobiomic analysis of glucosamine sulfate, prebiotics and non-steroidal anti-inflammatory drugs | Abstract similar documents |
O. A. Gromova, I. Yu. Torshin, A. V. Naumov, V. A. Maksimov | ||
Vol 15, No 1 (2022) | Study of methods for state regulation of prices and costs of the health care system for medicines in the United Kingdom | Abstract similar documents |
A. A. Leshkevich, D. S. Yurochkin, Z. M. Golant, I. A. Narkevich | ||
Vol 14, No 4 (2021) | Economic burden of chronic viral hepatitis C | Abstract similar documents |
R. A. Yakhina, I. A. Lakman, D. A. Valishin, R. Kh. Bakhitova | ||
Vol 16, No 3 (2023) | Retrospective pharmacoeconomic study of antibiotic therapy in community-acquired pneumonia | Abstract similar documents |
A. A. Taube, T. V. Alexandrova, O. A. Demidova, M. V. Zhuravleva | ||
Online First | Chemo-рroteomic analysis of the pharmacological properties of vitamin В12 derivatives | Abstract similar documents |
I. Yu. Torshin, O. A. Gromova, I. A. Dereven’kov, L. A. Maiorova | ||
Vol 12, No 1 (2019) | The use of the level of evidence and grade of recommendations scales in developing clinical guidelines in the Russian Federation | Abstract similar documents |
N. I. Zhuravleva, L. C. Shubina, O. A. Sukhorukikh | ||
Vol 15, No 3 (2022) | Prospects for the use of chondroitin sulfate and glucosamine sulfate in the treatment of patients with obesity-associated osteoarthritis (metabolic syndrome) | Abstract similar documents |
I. Yu. Torshin, О. A. Gromova, A. M. Lila | ||
"... of obesity. By inhibiting O-glucosamination of intranuclear proteins (i.e., p53), GS can accelerate lipolysis ..." | ||
Vol 16, No 1 (2023) | Systematic computer analysis of the pharmacology of bioflavonoids in the context of increasing the body's antiviral defenses | Abstract similar documents |
O. A. Gromova, I. Yu. Torshin, A. G. Chuchalin | ||
Vol 14, No 2 (2021) | Systematic computer analysis of published literature on nutritional support for vaccination | Abstract similar documents |
A. G. Chuchalin, I. Yu. Torshin, O. A. Gromova | ||
Vol 13, No 2 (2020) | Is it worthwhile rethinking the positive experience of the last 50 years of using chondroitin sulfates against atherosclerosis? | Abstract similar documents |
A. M. Lila, I. Yu. Torshin, O. A. Gromova | ||
"... биологические эффекты фактора некроза опухолей-a (ФНО-a). Избыточная активность NF-kB также стимулирует и ..." | ||
Vol 13, No 4 (2020) | Evaluation of the economic effect of biological therapy in patients with severe COVID-19 and cytokine storm | Abstract similar documents |
M. Yu. Frolov, A. S. Salasyuk, V. A. Rogov | ||
Vol 14, No 4 (2021) | Hepatoprotective effects of chondroitin sulfate and glucosamine sulfate | Abstract similar documents |
I. Yu. Torshin, A. M. Lila, O. A. Gromova | ||
1 - 50 of 146 Items | 1 2 3 > >> |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)